However, there is some evidence that vitamin D supplementation may improve blood pressure in individuals with serum 25(OH) vitamin D concentration less than 30 nanograms (ng)/mL
Research highlights significant improvements in body fat reduction, liver health, cholesterol profiles, and cardiovascular markers
For weight loss, healthcare professionals may prescribe GLP-1 receptor agonists if you have a starting body mass index (BMI) of 30 or higher or if you have a BMI of 27 or higher and at least 1 weight-related health condition, including: Type 2 diabetes Cardiovascular disease High blood pressure High cholesterol Liver disease Polycystic ovary syndrome Obstructive sleep apnea What are the common side effects of GLP-1 receptor agonists
Cytarabine promotes IL-1 secretion through NLRP3 inflammasomes, offering a novel approach to improve treatment strategies (117)
This approach requires careful monitoring and preferably medical supervision to improve dosing and prevent potential interactions
However, the FDA label explicitly states that "it is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of GLP-1 receptor agonist-induced rodent thyroid C-cell tumors has not been determined." The rodent thyroid has substantially more C-cells than the human thyroid, and rodents may be more susceptible to this effect